HULL HANS (Chief Business Officer) received a stock award from PLIANT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/27/2025ACC: 0001746473-25-000015
Officer· Chief Business Officer
Since Jun 2020
+120.45K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
120.45K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40.15K
Price / share
—
Trade value
—
% of position
19.0%
1/23/2025
211.56K→251.71K
Total
Net shares
+40.15K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2025 | A · Award | +40.15K | — | — | 19.0% | 211.56K | 251.71K |
| Total | +40.15K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
80.30K shares
Shares
+80.30K
Strike price
11.14
Held after
80.30K
Exercisable
—
1/23/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock80.30K shares | 1/23/2025 | A · Award | +80.30K | 11.14 | — | 80.30K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned13.98K
Common Stock
IndirectShares owned13.98K
Common Stock
IndirectShares owned3.82K
Total
31.79K indirect31.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13.98K | Indirect |
| Common Stock | 13.98K | Indirect |
| Common Stock | 3.82K | Indirect |
| Total | 31.79K | 31.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported